Transcatheter Mitral Valve Replacement Market (TMVR) Analysis, Opportunities and Forecast 2017 to 2022

The research study focuses on Global Transcatheter Mitral Valve Replacement (TMVR) Market major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information.

Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.

The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.

Company Profiling are Edward Lifecsiences Incorporation, Abbott Laboratories and Medtronic.

Order a copy of this research report ($800) at https://www.marketinsightsreports.com/report/purchase/10121014?mode=su

Growth of the overall global TMVR market has also been forecasted for the years 2017-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Edward Lifesciences, Medtronic, and Abbott Laboratories are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time.

The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.

Complete report of 58 pages with TOC is available at https://www.marketinsightsreports.com/reports/10121014/global-transcatheter-mitral-valve-replacement-tmvr-market-2017-to-2022

There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.

Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2017-2022). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.

List of Figures

Figure 1: Transcatheter Mitral Valve Timeline
Figure 2: Transcatheter Mitral Valve Clinical Guidelines
Figure 3: Global MR Market by Number of Patients; 2014-2016 (Million)
Figure 4: Global MR Market by Number of Patients; 2017-2022 (Million)
Figure 5: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2016
Figure 6: Global MR Market by Patient Severity and Eligibility for Treatment; 2017-2022
Figure 7: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 8: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 9: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Figure 10: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
Figure 11: Global TMVR Market by Value; 2014-2016 (THE US$ Million)
Figure 12: Global TMVR Market by Value; 2017-2022 (THE US$ Million)
Figure 13: Global TMVR Market by Volume; 2014-2016 (Units)
Figure 14: Global TMVR Market by Volume; 2017-2022 (Units)
Figure 15: The US MR Market by Number of Patients; 2014-2022 (Million)
Figure 16: The US MR Market by Patient Severity; 2014-2022
Figure 17: The US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 18: The US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 19: The US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 20: The US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 21: The US TMVR Market by Value ; 2016-2022 (THE US$ Million
Figure 22: The US TMVR Market by Volume; 2016-2022 (Units)
Figure 23: Europe MR Market by Number of Patients; 2014-2022 (Million)
Figure 24: Europe MR Market by Patient Severity; 2014-2022 (Million)
Figure 25: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 26: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 27: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 28: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 29: Europe TMVR Market by Value; 2014-2022 (THE US$ Million)
Figure 30: Europe TMVR Market by Volume; 2014-2022 (Units)
Figure 31: Global TMVR Market by Top Four Players; 2016 (THE US$ Billion)
Figure 32: Edward Lifesciences Net sales; 2012-2016 (THE US$ Billion)
Figure 33: Edward Lifesciences Net sales by Segments; 2016 (Percentage, %)
Figure 34: Edward Lifesciences Net sales by Regions; 2016 (Percentage, %)
Figure 35: Abbott Laboratories Net Sales; 2012-2016 (THE US$ Billion)
Figure 36: Abbott Laboratories Net Sales by Segments; 2016 (Percentage, %)
Figure 37: Medtronic Net Sales; 2012-2016 (THE US$ Billion)
Figure 38: Medtronic Net Sales by Segments; 2016 (Percentage, %)
Figure 39: Medtronic Net Sales by Regions; 2016 (Percentage, %)

Contact Info:
Name: Diane Conrad
Email: Send Email
Organization: Market Insights Reports
Website: https://www.marketinsightsreports.com/reports/10121014/global-transcatheter-mitral-valve-replacement-tmvr-market-2017-to-2022

Release ID: 249391